Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study.

Trial Profile

Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 08 Aug 2014

At a glance

  • Drugs Aripiprazole (Primary) ; Lithium; Valproic acid
  • Indications Bipolar I disorders; Depressive disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Jul 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 08 Feb 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 01 Feb 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top